---
format: 
  revealjs:
    navigation-mode: vertical
    slide-number: false
    width: 1600
    height: 900
    logo: "images/revelo.png"
    footer: "[home page](https://revelo-rnaseq.github.io/2024_RNASeq_website)"
    css: ["css/theme.css", "css/custom.css"]
    theme: simple
    controls: true
mainfont: "Times New Roman"
editor: source
filters:
  - roughnotation
editor_options: 
  chunk_output_type: inline
---

##  {#TitleSlide data-menu-title="TitleSlide" background-image="images/back001.jpg" background-size="cover" background-opacity="0.3"}

```{r setup, include=FALSE}
library(fontawesome)
library(tidyverse)
library(quarto)
library(gt)
library(gtExtras)
library(gtsummary)

# font-family: 'Architects Daughter', cursive;
# font-family: 'Julius Sans One', sans-serif;
# font-family: 'Montserrat', san  s-serif;
# font-family: 'Rock Salt', cursive;
```

<style>
  @import url('https://fonts.googleapis.com/css2?family=Architects+Daughter&family=Julius+Sans+One&family=Montserrat:wght@300&family=Rock+Salt&display=swap');
</style>

::: {style="position: absolute; left: 180px; top: 200px; height: 525px; width: 1500px; background-color: #69b1e9; padding: 20px; padding-left: 50px; border-radius: 5px;"}
[Introduzione all'RNASeq]{style="font-size: 120px; font-weight: bold; line-height: 1em; margin: 0px; font-family: 'Architects Daughter', cursive;"}

[Introduzione all'analisi RNASeq in R]{style="font-size: 40px;font-weight: bold;"}

[Dipartimento di Biomedicina e Prevenzione]{style="font-size: 40px;font-weight: bold;"}

<br> <br>

[Marco Chiapello, Revelo Datalab]{style="font-size: 40px; font-weight: bold;"}

[2024-11-18]{style="font-size: 30px;font-weight: bold;"}
:::

#  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}


[Introduction to RNA Sequencing]{.tit .p-span-center}

[(Primary analysis)]{.p-span-center}

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[The central dogma]{.subtit}

::: {.p-img-center}
![](images/dogma.png)
:::

:::{.tcenter}
*   **DNA:** The blueprint of genetic information
*   **RNA:** The messenger carrying genetic instructions
*   **Protein:** The functional molecules in cells
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Why Study RNA?]{.subtit}

::: {.p-img-center}
```{r}
#| echo: false
#| layout-ncol: 1
plot(qrcode::qr_code("https://forms.gle/b6byBimmjCfM91uU6"))
```

:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Why Study RNA?]{.subtit}

:::: {.columns}
::: {.column width="40%"}
![](images/NMFaheatmap-1.png){width=400}
:::
::: {.column .f40}
*   **Dynamic reflection of cellular activity:**  Unlike DNA, which is relatively static, RNA levels change rapidly in response to internal and external stimuli. 
    *   Provides a snapshot of what genes are actively being expressed at a specific time.
*   **Understanding gene regulation:** Studying RNA helps us understand how genes are turned on or off, and to what extent, in different conditions.
:::
:::: 

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Why Study RNA?]{.subtit}

::: {.columns}
::: {.column width="40%"}
![](images/NMFaheatmap-1.png){width=400}
:::
::: {.column .f40}
*   **Insights into cellular processes:**  RNA plays diverse roles in many cellular processes, including:
    *   Protein synthesis (mRNA)
    *   Gene regulation (microRNAs, long non-coding RNAs)
    *   Catalysis (ribozymes)
*   **Disease biomarkers and drug targets:**  Changes in RNA expression can be indicative of disease states, making RNA a valuable source of biomarkers for diagnosis and prognosis. 
:::
::: 


<!-- ##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Why RNA Sequencing?]{.subtit}

::: {.columns .f60}
::: {.column}
*   **Microarrays:**
    *   Limited to known genes
    *   Lower sensitivity
    *   Hybridization biases
:::
::: {.column}
*   **RNA-Seq:**
    *   Unbiased and comprehensive
    *   Higher sensitivity
    *   Wider range of applications
:::
::: 

::: {.notes}
- **Limitations of older techniques**: Explain that while microarrays were useful, they had significant drawbacks

- **Enter RNA-Seq**: Introduce RNA-Seq as a revolutionary technology that overcomes these limitations
 
---

- **Create a sense of progress**: Explain how RNA-Seq represents a significant advancement over previous methods.

- **Highlight the "discovery" aspect**: Emphasize that RNA-Seq allows researchers to explore the unknown and uncover new biological insights.
::: -->

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[The Power of RNA-Seq]{.subtit}

::: {.columns}
::: {.column}
*   **Unbiased & Comprehensive:**
    *   Discovers novel transcripts
    *   Not limited to known genes

*   **Higher Sensitivity:**
    *   Detects rare transcripts
    *   Wider dynamic range
:::
::: {.column}
*   **Alternative Splicing:**
    *   Identifies and quantifies isoforms

*   **Mutation Detection:**
    *   SNPs, indels, fusion genes

*   **Non-Coding RNAs:**
    *   Studies microRNAs, lncRNAs, etc.
:::
::: 



::: {.notes}
- "Wide dynamic range" refers to the ability of a system or device to accurately capture and represent a broad range of signal intensities

- lncRNAs, or long non-coding RNAs, are a type of RNA molecule that is not translated into protein.  They were once considered "junk" DNA, but are now recognized as crucial regulators of gene expression and cellular processes
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[A Brief History of Sequencing]{.subtit}


::: {.p-img-center}
```{r}
#| echo: false
#| layout-ncol: 1
plot(qrcode::qr_code("https://forms.gle/rWcwyAiA4L7EG8pm7"))
```

:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[First generation NGS]{.tit .p-span-center}


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sanger Sequencing]{.subtit}

<br>

:::{.p-img-center}
![](images/sanger1.png){width=1500}
:::

:::{.notes}
- I dideossinucleotidi trifosfati (ddNTP) mancano del gruppo 3'-OH dei dNTP, essenziale per l'allungamento del filamento mediato dalla polimerasi in una PCR.

- Le marcature radioattive, instabili, rappresentavano un rischio per la salute e richiedevano gel separati per ciascuna delle quattro basi del DNA.

- La sintesi del filamento di DNA complementare inizia nel sito specifico di innesco e termina con l'incorporazione di un ddNTP terminatore di catena che viene introdotto casualmente al posto del corrispondente dNTP.

- Quando questi frammenti vengono separati su una matrice di gel appropriata, l'informazione sulla sequenza può essere ottenuta dall'ordine di migrazione delle bande (dal basso verso l'alto).
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sanger Sequencing]{.subtit}

<br>

:::{.p-img-center}
![](images/sanger2.png){width=1500}
:::

:::{.notes}
- Leroy Hood sviluppò una tecnica chimica che utilizzava coloranti fluorescenti di diversi colori, uno per ciascuna delle quattro basi del DNA. Questo sistema di "codifica a colori" eliminò la necessità di eseguire diverse reazioni in gel sovrapposti.

- Hood integrò la tecnologia laser e informatica, eliminando il tedioso processo di raccolta manuale delle informazioni.

- ddATP, ddCTP, ddGTP e ddUTP marcati con fluorescenza.

- La successiva visualizzazione fluorescente del prodotto rivela il nucleotide incorporato e quindi la sequenza.
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sanger Sequencing ]{.subtit}

:::: {.columns .f30}

::: {.column width="40%"}
**Advantages** {{< fa face-smile-beam >}}

1. Gold standard method for accurate detection of single nucleotide variants and small insertions/deletions

1. Cost effective where single samples need to be tested very urgently

1. Less reliant on computational tools than NGS

1. Longer fragments (up to approximately 1000bp) can be sequenced than in short read NGS
:::

::: {.column width="10%"}
:::

::: {.column width="40%"}
**Limitations** {{< fa face-tired >}}

1. Limited throughput

1. Not cost effective for sequencing many genes in parallel

1. Can require a larger amount of input DNA than NGS

1. Sanger methods can only sequence short pieces of DNA--about 300 to 1000 base pairs.

1. The quality of a Sanger sequence is often not very good in the first 15 to 40 bases because that is where the primer binds.

1. Sequence quality degrades after 700 to 900 bases
:::

::::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sanger Sequencing ]{.subtit}

::: {.p-img-center}
```{r}
#| echo: false
#| layout-ncol: 1
plot(qrcode::qr_code("https://forms.gle/b6byBimmjCfM91uU6"))
```

:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Second generation NGS]{.subtit}

<br>

:::{.callout-important appearance="default"}
[Second-generation NGS machines immediately began to drive the ‘genomics revolution’ by massively increased throughput by parallelizing many reactions]{style="font-size: 50px; font-family: 'Julius Sans One', sans-serif"}
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Second generation NGS]{.subtit}

<br>

Second-generation sequencing platforms:

1. SOLiD: Sequencing by Oligonucleotide Ligation and Detection

1. 454 GS FLX+: It uses pyrosequencing chemistry

1. NextSeq 550Dx: Sequence by synthesis

:::{.notes}
1. SOLiD: Life Technologies in 2006

1. 454: Roche in 2011

1. NextSeq 550Dx: Illumina in 2017 
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by Ligation]{.subtit}

<br>

::::{.columns}

:::{.column width="55%"}
:::{.r-stack .p-img-center}
![](images/lig1.png){width="900"}

![](images/lig2.png){.fragment width="900"}
:::
:::

:::{.column width="45%"}

<br>

:::{.fragment}
- `r fontawesome::fa("plus-circle", fill = "green")` Considered to be one of the most accurate second-generation sequencing technologies

- `r fontawesome::fa("minus-circle", fill = "red")` it can take up to seven days to complete a  single run and its short read length of 35 bp

- `r fontawesome::fa("minus-circle", fill = "red")` Thermo Fisher Scientific shut down all SOLiD sequencing platforms in 2016
:::
:::
::::

:::{.notes}
- Fluorescently labeled molecules called 8-mers

- 8-mers are short ssDNA fragments where: 

    - the first and second nucleotides are the next two nucleotides of the elongating DNA strand    
    - the third-to-fifth nucleotides are degenerate     
    - the sixth to eighth nucleotides are inosine bases, where the eighth inosine base is attached to a characteristic fluorescent dye

A. The addition of primer and 8-mers, where if the first two nucleotides are complementary, DNA ligase ligates it to the primer.    
B. Unbound 8-mers are washed away, and a laser excites the fluorescent tag on the 8-mer to emit a detectable light signal that is captured    
C. A-B is repeated until the end of the DNA fragment.    
D. The newly synthesized DNA strand is melted off, and A-C is repeated using a primer with a length of N-1, N-2, and N-3

:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Pyrosequencing]{.subtit}

::::{.columns}

:::{.column width="45%"}
:::{.p-img-center}
![](images/pyro.png){width=800}
:::

:::

:::{.column width="10%"}
:::

:::{.column width="45%"}
<br>
<br>

:::{.fragment}
- `r fontawesome::fa("plus-circle", fill = "green")` Large read lenght generation

- `r fontawesome::fa("minus-circle", fill = "red")` High reagent cost

- `r fontawesome::fa("minus-circle", fill = "red")` High error rate for homopolymers
:::
:::
::::

:::{.notes}
Durante il sequenziamento vengono, di volta in volta, aggiunti dei nucleotidi. 

Se il nucleotide viene incorporato viene rilasciato un pirofosfato 

Poi utilizzato come substrato dall’enzima ATP solforilasi. 

Quest’ultimo enzima catalizza la conversione del pirofosfato in ATP. 

L’ATP a sua volta è il cofattore utilizzato dalla luciferasi per catalizzare la reazione che coinvolge la luciferina e che porta alla produzione di luce. 

La luce generata, solo in seguito alla incorporazione del nucleotide corretto,viene rilevata grazie ad un detector.
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis]{.subtit}

##  {background-image="images/pant.jpg" background-size="cover" background-opacity="1"}

:::{.notes}
Birthplace of high-throughput sequencing
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis - History]{.subtit}

<br>

[1997]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [Evolution of a Novel Approach to Sequencing]{style="font-size: 70px"}

:::{.p-img-center}
![](images/bk.jpg){width=600}
:::

:::{.tcenter}
Shankar Balasubramanian and David Klenerman
:::


:::{.notes}
- Cambridge scientists Shankar Balasubramanian, Ph.D. and David Klenerman, Ph.D. were using fluorescently labeled nucleotides to observe the motion of a polymerase at the single molecule level as it synthesized DNA immobilized to a surface

- during the summer of 1997 sparked ideas surrounding the use of clonal arrays and massively parallel sequencing of short reads using solid phase sequencing by reversible terminators

- This technology was subsequently referred to as sequencing by synthesis technology, or SBS. This became the basis of an innovative DNA sequencing approach.
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis - History]{.subtit}

<br>

[1998]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [Formation of Solexa]{style="font-size: 70px"}

:::{.p-img-center}
![](images/solexa.png){width=600}
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis - History]{.subtit}

<br>

[2004]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [Molecular Clustering Technology Integration]{style="font-size: 70px"}

:::{.p-img-center}
![](images/polony.jpg){width=800}
:::

:::{.tcenter}
Cluster generation (also known as “bridge amplification”)
:::


:::{.notes}
- Solexa acquired molecular clustering technology from Manteia. 

- The amplification of single DNA molecules into clusters enhanced the fidelity and accuracy of gene calling, while reducing the cost of the system optics through generation of a stronger signal.
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis - History]{.subtit}

<br>

[2005]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [phiX-174 Genome Sequencing]{style="font-size: 70px"}

:::{.fragment}
[2005]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [Integration of Lynx Therapeutics]{style="font-size: 70px"}
:::

:::{.fragment}
[2007]{style="font-family: 'Rock Salt', cursive;font-size: 60px"}: [Illumina Acquires Solexa]{style="font-size: 70px"}

::::{.columns}

:::{.column width="45%"}
:::{.p-img-center}
![](images/ga.jpg){width=500}
:::

:::

:::{.column width="10%"}
:::

:::{.column width="45%"}
:::{.p-img-center}
![](images/moore.png){width=500}
:::

:::

::::

:::


:::{.notes}
- The Solexa team sequenced the complete genome of the bacteriophage phiX-174, the same genome Sanger first sequenced using his method

- However, the SBS technology generated significantly more sequencing data, delivering over 3 million bases from a single run.

---

- Solexa acquired instrumentation company Lynx Therapeutics, transforming the successful Solexa prototype into a commercial sequencing instrument: Genome Analyzer

---

- Solexa was acquired by Illumina

- Next-generation sequencing (NGS) data output has increased at a rate that outpaces Moore's law, more than doubling each year
:::



##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sequence by synthesis - Process]{.subtit}

{{< video https://www.youtube.com/embed/fCd6B5HRaZ8 width="100%" height="85%" >}}


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Third generation NGS]{.subtit}

<br>

:::{.callout-important appearance="default"}
[Third-generation methods allow direct sequencing of single DNA molecules]{style="font-size: 50px; font-family: 'Julius Sans One', sans-serif"}
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Third generation NGS]{.subtit}

<br>

Third-generation NGS platforms:

1. Single-molecule real-time sequencing

1. Nanopore sequencing

:::{.notes}
1. Pacific Biosciences in 2011

1. Oxford Nanopore Technologies on 2014
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[SMRS]{.subtit}


{{< video https://www.youtube.com/embed/_lD8JyAbwEo width="100%" height="85%" >}}

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Nanopore sequencing]{.subtit}


{{< video https://www.youtube.com/embed/CGWZvHIi3i0 width="100%" height="85%" >}}

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Single-Ended vs. Paired-End]{.subtit}

**Choosing Your Sequencing Strategy**

:::{.p-img-center}
![](images/SE_vs_PE.png){width=1000}
:::

::: {.columns .f30}
::: {.column width="30%"}
*   **Single-end sequencing:**
    *   One read per fragment
    *   Simpler, cost-effective
    *   Suitable for gene expression profiling
:::
::: {.column width="30%"}
*   **Paired-end sequencing:**
    *   Two reads per fragment
    *   More information, improved accuracy
    *   Useful for genome assembly, variant detection, isoform identification
:::
::: {.column width="30%"}
*   **Choice depends on:**
    *   Research question
    *   Budget
    *   Desired accuracy

:::
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Single-Ended vs. Paired-End]{.subtit}

| Trade-off             | Single-End Sequencing | Paired-End Sequencing |
|-----------------------|-----------------------|-----------------------|
| **Cost**              | Lower                 | Higher                |
| **Information**       | Less                  | More                  |
| **Simplicity**        | Simpler               | More Complex          |
| **Accuracy**          | Lower                 | Higher                |
| **Sequencing Depth**  | Higher                | Potentially Lower      |
| **Read Length**       | Shorter               | Longer (effective)    |
| **Ideal Applications** | Gene expression, small RNA-Seq | Genome assembly, variant calling, isoform identification |

#  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}


[Sample Preparation]{.tit .p-span-center}


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Sample Preparation]{.subtit}

<br>
<br>

:::{.p-img-center}
![](images/sample_top.png)
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[RNA Extraction]{.subtit}


::: {.columns}
::: {.column width="40%"}
![](images/rnaE.png){width=400}
:::

::: {.column width="60%"}
*   **Goals:**
    *   Lyse cells/tissues
    *   Remove contaminants (DNA, proteins, lipids)
    *   Preserve RNA integrity
*   **Methods:**
    *   Phenol-chloroform extraction {{< fa circle-xmark >}}
    *   **Column-based kits** (silica membrane) {{< fa trophy >}}
:::
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Importance of High-Quality RNA]{.subtit}

::: {.columns}
::: {.column width="40%"}
![](images/bioanal.png){width=600}
:::
::: {.column width="60%"}
*   High-quality RNA is the cornerstone of successful RNA-Seq.
*   Degraded or contaminated RNA can lead to:
    *   Inaccurate gene expression measurements
    *   Misleading conclusions
    *   Wasted time and resources
*   Prevent RNA degradation:
    *   Use RNase-free reagents and equipment.
    *   Store RNA at -80°C.
    *   Minimize freeze-thaw cycles.
:::
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Enrich a specific type of RNA]{.subtit}

- mRNA

- rRNAs and tRNAs (involved in mRNA translation)

- Small nuclear RNAs (involved in splicing)

- Small nucleolar RNAs (involved in the modification of rRNAs)

- microRNA (regulate gene expression at the posttranscriptional level)

- Long noncoding RNAs (chromatin remodelling, transcriptional control and posttranscriptional processing)


#### Two options for mRNA enrichment 

- **mRNA enrichment** – Selectively enriching for poly(A)-tailed transcripts

- **RNA depletion** – Selectively depleting abundant/off-target transcripts 

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[RNA Fragmentation]{.subtit}

:::{.callout-important}
[A sequencing library is essentially a pool of RNA fragments with adapters attached]{style="font-size: 40px"}
:::


*   **Why?**
    *   NGS platform compatibility
    *   Increased library complexity
*   **Methods:**
    *   Enzymatic digestion (e.g., RNase III)
    *   Mechanical shearing (e.g., sonication)


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Attachment of adapters]{.subtit}

1. Adapters are a short, chemically-synthesised oligonucleotide that can be attached to the ends of DNA molecules (cDNA Synthesis: RNA to DNA)

1. Act as barcodes to identify where each nucleotide was originally located

:::{.p-img-center}
![](images/adapter.png){width=900}
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Library quantification]{.subtit}

::: {.columns}
::: {.column width="40%"}
![](images/rin.jpg){width=600}
:::
::: {.column width="60%"}
*   **Why quantify?**
    *   Optimal sequencing results
    *   Determine loading concentration
    *   Ensure even coverage
*   **Methods:**
    *   Fluorometric methods (e.g., Qubit)
    *   qPCR
    *   Capillary electrophoresis (e.g., Bioanalyzer)
:::
:::


#  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}


[Emerging Trends and Future Directions]{.tit .p-span-center}


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Single-Cell RNA Sequencing]{.subtit}

**Zooming In: Analyze gene expression in individual cells**

:::{.p-img-center}
![](images/scRNA1.jpg){width=1200}
:::

<!-- ::: {.columns}
::: {.column width="50%"}
*   **Advantages:**
    *   Cellular heterogeneity
    *   Cell-fate transitions
    *   Rare cell populations
:::
::: {.column width="50%"}
*   **Challenges:**
    *   Technical complexity
    *   Cost
    *   Data analysis
:::
::: -->

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Single-Cell RNA Sequencing]{.subtit}

**scRNA-Seq: advantages in biological research**

*   **Cellular Heterogeneity:**  Identify and characterize different cell types within a complex tissue or population.
    *   Discover new cell subtypes and rare cell populations.
    *   Understand the functional diversity of cells.
*   **Developmental Trajectories:**  Trace cell lineages and reconstruct developmental pathways.
    *   Study cell differentiation and fate decisions.
    *   Identify key genes and regulatory networks involved in development.


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Single-Cell RNA Sequencing]{.subtit}

**scRNA-Seq: advantages in biological research**

*   **Disease Mechanisms:**  Investigate the cellular basis of disease.
    *   Identify disease-associated cell types and gene expression changes.
    *   Study the response of individual cells to drugs or treatments.


:::{.callout-important appearance="default"}
scRNA-seq represents a powerful tool for dissecting the complexities of gene expression and cellular heterogeneity across various biological contexts
:::



##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Spatial Transcriptomics]{.subtit}

**Spatial Transcriptomics: mapping gene expression in context**

::: {.columns}
::: {.column width="40%"}
<br>
<br>

![](images/sptr.png){width=600}

:::
::: {.column width="60%" .f30}
*   **Bridges histology and genomics:** Combines traditional tissue imaging with high-throughput RNA sequencing.
*   **Preserves spatial context:**  Maps gene expression while retaining spatial information, unlike traditional scRNA-seq.
*   **Enables:**
    *   Visualization of gene expression patterns within tissues.
    *   Quantitative analysis of transcriptomes in a spatial context.
*   **Applications:**
    *   Understanding tissue organization and cellular interactions.
    *   Investigating developmental processes (organogenesis).
    *   Studying disease progression and heterogeneity.

:::
:::



##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Spatial Transcriptomics]{.subtit}


**Spatial Transcriptomics: from technology to discovery**

::: {.columns}
::: {.column width="40%"}
![](images/sctr2.jpg){width=600}
:::
::: {.column width="60%" .f30}
*   **Applications:**
    *   **Tissue heterogeneity:**  Studying complex tissues like the cochlea. (Tisi, 2023)
    *   **Disease mechanisms:**  Uncovering cellular dynamics in diseases like Alzheimer's. (Chen et al., 2020)
*   **Data analysis:**
    *   Dimension reduction, deconvolution, and integration with histological images.
    *   Specialized tools for cell type deconvolution. (Cable et al., 2021)

:::
:::


##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Integration of RNA-Seq with other omics data]{.subtit}

**Beyond RNA: integrating with other omics data**

::: {.f30}
*   **The Power of Integration:** Combining RNA-Seq with other omics data provides a more complete picture of cellular processes.
    *   **Metabolomics:**  Correlate gene expression with metabolic pathways and identify key metabolites.
    *   **Chromatin accessibility (ATAC-seq):**  Link gene expression changes to alterations in chromatin structure.
    *   **Other omics layers:**  Integrate with genomics, proteomics, and epigenomics for a systems-level understanding.
*   **Key Findings:**
    *   Limited overlap between DEGs and chromatin accessibility changes (~10%) (Malvi et al., 2022).
    *   Highlights the complexity of gene regulation beyond chromatin state. (Miao et al., 2021)
:::

##  {background-image="images/back001.jpg" background-size="cover" background-opacity="0.1"}

[Integration of RNA-Seq with other omics data]{.subtit}

**Unlocking biological insights through data integration**

::: {.columns}
::: {.column width="40%"}
![](images/integr.jpeg){width=500}
:::
::: {.column width="60%" .f25}
*   **Applications:**
    *   **Identifying key pathways:**  Integration of RNA-seq and metabolomics reveals regulated pathways in liver metabolism. (Zhang et al., 2020)
    *   **Disease biomarkers:**  Uncovering disease-specific biomarkers in NAFLD using RNA-seq and metabolomics. (Ji et al., 2022)
*   **Tools and Techniques:**
    *   **Machine learning:**  rSeqTU for predicting transcription units and integrating with metagenomics and metabolomics. (Hou et al., 2022)
    *   **Statistical analysis:**  DESeq2 for integrating RNA-seq and ChIP-seq data. (Niu et al., 2019)
    *   **Single-cell multi-omics:**  Combining scRNA-seq with lipidomics and metabolomics to study cellular heterogeneity. (Cao et al., 2020)

:::
:::


#  {background-image="images/qmark.jpg" background-size="cover" background-opacity="0.7"}


::: {style="position: absolute; left: 980px; top: 450px;"}
[Domande?]{style="font-size: 130px; font-weight: bold; color: white"}
:::

